At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Rebreathing-induced hypoxia +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Rebreathing-induced Hypoxia on the Response to an Oral Glucose Tolerance Test
In Brief
A clinical study evaluating Rebreathing-induced hypoxia and Spontaneous breathing for Hypoxemia. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The aim of this research project is to determine the effect of repeated maximal voluntary apneas on glucose uptake during an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypoxemia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
First PostedJun 2022
Primary CompletionSep 2023
Study CompletionOct 2025
TodayJul 2026
First PostedJun 16, 2022
Enrollment StartOct 21, 2021
Primary CompletionSep 4, 2023
Study CompletionOct 13, 2025
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 4.0 years ago
Interventions
Rebreathing-induced hypoxiabehavioral
Participants will rebreathe room air from a low-volume closed-circuit system for a period of 2 minutes.
Spontaneous breathingbehavioral
Participants will be spontaneously breathing during an oral glucose tolerance test.